| Daunomycin |
| 20830-81-3 |
| Acetyladriamycin |
| Leukaemomycin C |
| Rubidomycin |
| Cerubidine |
| (+)-Daunomycin |
| DaunoXome |
| Daunorubicinum |
| Daunorubicine |
| Cerubidin |
| RP 13057 |
| Rubomycin C |
| FI 6339 |
| Daunorubicin (INN) |
| NSC-82151 |
| Daunarubicinum |
| Daunorrubicina |
| DaunoXome (TN) |
| Daunamycin |
| FI-6339 |
| FI6339 |
| ZS7284E0ZP |
| (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione |
| (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione |
| DTXSID7022883 |
| CHEBI:41977 |
| RP-13057 |
| NCGC00024246-05 |
| Anthracycline |
| Anthracyline |
| NDC-0082-4155 |
| DAUNORUBICIN [INN] |
| 5,12-Naphthacenedione,8-acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)- |
| Daunorubicinum [INN-Latin] |
| DTXCID402883 |
| MLS000069508 |
| Daunorubicin [INN:BAN] |
| NSC-83142 |
| RCRA waste no. U059 |
| (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside |
| (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione |
| (8S,10S)-8-acetyl-10-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione |
| CAS-20830-81-3 |
| NSC82151 |
| SMR000058559 |
| CCRIS 914 |
| SR-01000000033 |
| SR-05000001600 |
| HSDB 5095 |
| NCI-C04693 |
| EINECS 244-069-7 |
| NSC 83142 |
| VS-103 |
| BRN 1445583 |
| Tocris-1467 |
| Daunorubicin(Daunomycin) |
| AI3-52942 |
| Prestwick3_000487 |
| DAUNOMYCIN [IARC] |
| DAUNORUBICIN [MI] |
| CHEMBL178 |
| DAUNORUBICIN [HSDB] |
| SCHEMBL3041 |
| DAUNORUBICIN [VANDF] |
| EPIRUBICIN IMPURITY D |
| UNII-ZS7284E0ZP |
| BSPBio_000353 |
| DAUNORUBICIN [MART.] |
| 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)- |
| cid_62770 |
| DAUNORUBICIN [WHO-DD] |
| BPBio1_000389 |
| GTPL7063 |
| BDBM32017 |
| EX-A1337A |
| Valrubicin impurity, daunorubicin |
| STQGQHZAVUOBTE-VGBVRHCVSA-N |
| Daunomycin;RP 13057;Rubidomycin |
| DAUNORUBICIN [ORANGE BOOK] |
| HMS2089H04 |
| HMS2091K06 |
| Pharmakon1600-01500223 |
| VYXEOS COMPONENT DAUNORUBICIN |
| Tox21_110896 |
| BDBM50368352 |
| GR-318 |
| HY-13062A |
| LMPK13050002 |
| MFCD00866340 |
| NSC756717 |
| Tox21_110896_1 |
| CCG-212559 |
| CS-2004 |
| DB00694 |
| NSC-756717 |
| NCGC00024246-06 |
| NCGC00024246-07 |
| NCGC00024246-09 |
| NCGC00024246-10 |
| NCGC00024246-12 |
| NCGC00024246-15 |
| NCGC00024246-18 |
| NCGC00025173-01 |
| (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside |
| (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside |
| (7S,9R)-9-Acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione |
| (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione |
| 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)- |
| SBI-0206677.P002 |
| AB00514669 |
| C01907 |
| D07776 |
| Epirubicin hydrochloride impurity, daunorubicin- |
| AB00514669-09 |
| AB01644616_09 |
| AB01644616_10 |
| EN300-7479232 |
| A814957 |
| Q411659 |
| SR-01000000033-4 |
| SR-05000001600-1 |
| SR-05000001600-2 |
| BRD-K43389675-001-01-3 |
| BRD-K43389675-003-02-7 |
| BRD-K43389675-003-03-5 |
| BRD-K43389675-003-20-9 |
| EPIRUBICIN HYDROCHLORIDE IMPURITY D [EP IMPURITY] |
| VALRUBICIN IMPURITY, DAUNORUBICIN [USP IMPURITY] |
| 2-HYDROXY-5-(4-NITRO-PHENYLSULFAMOYL)-BENZOICACID |
| DOXORUBICIN HYDROCHLORIDE IMPURITY A [EP IMPURITY] |
| EPIRUBICIN HYDROCHLORIDE IMPURITY, DAUNORUBICIN- [USP IMPURITY] |
| (1S,3S)-3-ACETYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSIDE |
| (7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethanoyl-4-methoxy-6,9,11-tris(oxidanyl)-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride |
| (7S,9S)-9-acetyl-7-(4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl)oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione chloride |
| (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-quinone;hydrochloride |
| (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride |
| (7S,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride |
| (8S,10S)-8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-6,8,11-TRIHYDROXY-1-METHOXY-7,8,9,10-TETRAHYDROTETRACENE-5,12-DIONE |
| (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro--6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione |
| 5,12-NAPHTHACENEDIONE, 8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL))OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, (8S-CIS)- |
|
There are more than 10 synonyms. If you wish to see them all click here.
|